Pain Management Techniques for Liver Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two pain management techniques to determine which aids recovery better after liver surgery. Researchers compare thoracic epidural analgesia, which delivers pain medication through a small tube in the back, with a four-quadrant transversus abdominus plane block, where pain relief targets the abdominal muscles directly. It focuses on patients undergoing liver surgery for cancer without bowel surgery. Participants must sign a consent form and should not have had any recent major surgeries or chronic narcotic use. As a Phase 3 trial, this study represents the final step before FDA approval, offering patients a chance to contribute to potentially groundbreaking advancements in pain management.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does exclude those using therapeutic anticoagulation within 5 days of surgery and those with chronic narcotic use. It's best to discuss your specific medications with the trial team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that thoracic epidural analgesia (TEA) is generally safe for patients undergoing liver surgery. Studies have found that it typically does not lead to serious complications like infections or blood clots in patients without major blood clotting issues. TEA is also preferred for controlling post-surgical pain. However, about one in four patients might not experience full pain relief if the epidural is not placed correctly.
For the four-quadrant transversus abdominus plane (TAP) block, research indicates it is safe and carries a low risk of causing liver injury, especially when guided by ultrasound. It also helps reduce the need for strong painkillers, such as opioids, after surgery.
Both TEA and TAP block effectively manage pain, with studies showing no major difference in pain relief between the two. This suggests that both options are generally safe and effective for pain management after liver surgery.12345Why are researchers excited about this trial?
Researchers are excited about these pain management techniques for liver surgery because they offer innovative ways to control pain effectively. The Four-Quadrant Transversus Abdominus Plane (TAP) Block uses an ultrasound-guided delivery of bupivacaine, including a long-lasting liposomal version, directly to the abdominal nerves, potentially providing better localized pain relief than traditional systemic painkillers. On the other hand, Thoracic Epidural Analgesia involves placing a catheter near the spine to administer hydromorphone and bupivacaine, offering continuous pain relief in a more targeted manner than oral or intravenous medications. These methods aim to enhance recovery, minimize opioid use, and improve overall patient comfort compared to current options like systemic opioids or standard epidural techniques.
What evidence suggests that this trial's treatments could be effective for pain management in liver surgery?
Research has shown that thoracic epidural pain relief, one of the treatments in this trial, works effectively after major surgeries, such as liver operations. It succeeds in 91% of patients and reduces the need for additional pain medication, like opioids. This method also leads to better outcomes compared to standard painkillers administered through an IV.
For the four-quadrant transversus abdominus plane (TAP) block, another treatment option in this trial, studies suggest it helps manage pain and reduces opioid use in abdominal surgeries. However, it does not significantly speed up recovery. Both methods show promise for reducing pain after liver surgery, with thoracic epidural being slightly more effective.23678Who Is on the Research Team?
Timothy Newhook, MD
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
This trial is for patients scheduled for open liver surgery at MD Anderson Cancer Center, without bowel resection. They must have normal blood clotting measures, no fever or infections that would interfere with epidural placement, and not be on chronic narcotics. Pregnant women or those unable to follow the study are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-Surgery Preparation
Patients undergo placement of thoracic epidural catheter or ultrasound-guided, four-quadrant transversus abdominus plane block before surgery
Surgery and Immediate Post-Operative Care
Patients receive pain management via thoracic epidural analgesia or TAP block during and after liver surgery
Follow-up
Participants are monitored for safety, effectiveness, and recovery, including assessment of surgical complications and functional recovery
What Are the Treatments Tested in This Trial?
Interventions
- Four-Quadrant Transversus Abdominus Plane Block
- Thoracic Epidural Analgesia
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator